508 episodes
The Bio Report Levine Media Group
-
- Science
-
-
3.9 • 37 Ratings
-
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
-
A New Class of Cell Therapies to Target Solid Tumors
Jason Bock, CEO of CMTC, the joint venture between Resilience and MD Anderson Cancer Center, discusses the emerging area of TIL therapies, the significance of the first approved therapy in the class, and how they may address existing limitations of CAR-T therapies.
-
Targeting the Tumor Microenvironment with Lipid-Based Immunotherapies
Don Wyatt, chief business officer for Highfield Biopharmaceuticals, discusses the tumor microenvironment, HighField’s platform technology, and how it is developing lipid-based medicines to overcome challenges of existing immunotherapies.
-
A Company Born from a Father Who Wore His Heart on His Sleeve
Jeremiah Robison, CEO of Cionic, discusses the company’s Neural sleeve, how functional electronical stimulation helps people with movement disorders walk, and how the use of adaptive algorithms continuously optimizes the stimulation it delivers.
-
Using AI to Improve Burn Care
Pete Carlson, CEO of Spectral AI, discusses the company’s AI-driven DeepView System for assessing burns, how it provides clinicians an objective and immediate assessment of a wound’s healing potential, and how it changes outcomes for patients.
-
A Home for Biotech in the City that Never Sleeps
New York City is not the first place that comes to mind when thinking of biotech clusters, but the Big Apple has been a growing center of biomedical innovation with its mix of academic research hospitals, finance, and growing number of biopharmaceutical companies. One place that’s seeking to serve as both a home to innovative companies and facilitate collaborations is Cure, which describes itself as a healthcare innovation campus. We spoke to Seema Kumar, CEO of Cure, about how it operates, its various initiatives, and what can be done to accelerate the movement of innovative technologies from the lab to the marketplace.
-
Biopharma R&D Growing Stronger
Funding levels, drug launches, and R&D success rates all grew in 2023, according to a new report from the IQVIA Institute for Human Data Science. Global funding of biopharmaceutical research and development increased to $72 billion, up from $61 billion in 2022. M&A activity jumped to $140 billion from $78 billion during the same period. We spoke to Murray Aitken, executive director of the IQVIA Institute for Human Data Science, about its Global Trends in R&D 2024 report, what he’s watching, and why the new patent cliff for the industry will be less threatening than the last one.
Customer Reviews
Too loud
The content is interesting and it’s one of the podcasts I listen to most, but the advertisement and especially the jazz transition music is SO LOUD. When I’m driving and my hands are occupied, I actively cringe at the expectation of having my eardrums blasted when an episode begins or ends. When I’m not driving I try to skip ahead to the ~2 minute mark, because missing a bit of starting context from the actual show is worth preserving my hearing. Please make the audio levels consistent.
Poor interviewing skills
It is clear the host is just reading from a script. It’s very distracting the way he pauses in weird places in sentences. And then he essentially ignores what the guest is saying. No follow up questions, no listening, no semblance of conversation, just on to the next canned question. I suggest the host listens to his own interview with Kolluri—he rudely interrupts him several times, and for what reason? Simply to ask his next canned question! It’s so strange. It doesn’t sound like a big deal, but all of this is so distracting that it makes it difficult to focus on the content.
Good content
I am a longtime investor in Biotech and find the topics and interviews extremely interesting. The sound is not that good but it really doesn’t matter when the content is interesting. I would shorten the intro jingle by 50%. Keep up the good work.
Top Podcasts In Science